Advanced Filters
noise

Forde, Norway Clinical Trials

A listing of Forde, Norway clinical trials actively recruiting patients volunteers.

Found 5 clinical trials
Å Åsmund Flobak

Improving Public Cancer Care by Implementing Precision Medicine in Norway

IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating efficacy of commercially available, anti-cancer drugs prescribed for patients with advanced cancer diagnosed with potentially actionable alterations as revealed by molecular diagnostics. IMPRESS-Norway is a nation-wide study and all hospitals with an oncology and / or hematology department will be invited to …

16 - 100 years of age Both Phase 2
K Kari Anne Bjørnarå, PhD

A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

NOPARK is a double-blinded randomized controlled phase II trial, with the aim to assess the efficacy of nicotinamide adenine dinucleotide (NAD)-replenishment therapy in the form of oral nicotinamide riboside (NR) in delaying the progression of early Parkinson's disease (PD). A total of 400 persons with early stage Parkinson's disease will …

35 - 100 years of age Both Phase 3

PARASTOP - Paracetamol With Strong Opioids

Current guidelines recommend all people with cancer-related pain should be prescribed paracetamol, even those receiving high doses of strong pain killers (opioids) such as morphine. Although this has been shown in studies to be beneficial in other conditions, for instance dental work and after surgery, it has not been shown …

18 - 100 years of age Both Phase 3

The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.

Amyotrophic lateral sclerosis (ALS) is a serious rapidly progressive disease of the nervous system. The average survival from the time of diagnosis is 3 years. Apart from Riluzole, there is no effective treatment. Care of advanced ALS will have a cost of 4-8 million NOK per year Research i.a. from …

35 - 100 years of age Both Phase N/A
S Synøve Kalstad, MD

The Norwegian Antirheumatic Drug Register

NOR-DMARD is a register-based longitudinal observational study of which the main objectives are to study the effectiveness of treatment of inflammatory joint diseases with biological disease modifying anti-rheumatic drugs (DMARDs) in clinical practice, by measuring disease activity, health related quality of life, function and joint damage, and to study the …

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI